r Both the ATP-sensitive potassium (K ATP ) channel and the gaseous messenger nitric oxide (NO) play fundamental roles in protecting the heart from injuries related to ischaemia. r NO has previously been suggested to modulate cardiac K ATP channels; however, the underlying mechanism remains largely unknown.
Introduction
Vital in the adaptive response to (patho)physiological stress, the ATP-sensitive potassium (K ATP ) channel functions as a high-fidelity metabolic sensor, which couples intracellular metabolic state to membrane excitability (Ashcroft, 1988; Miki & Seino, 2005; Nichols, 2006) and serves a homeostatic role ranging from blood glucose regulation to cardioprotection (Olson & Terzic, 2010) . The K ATP channel is a hetero-octameric protein composed of four inwardly rectifying potassium channel subunits (Kir6.x) and four sulphonylurea receptors (SURx; Shyng & Nichols, 1997; Babenko et al. 1998) , whose molecular (subunit) composition exhibits tissue specificity. For example, in cardiac (ventricular) and skeletal muscles the K ATP channels are composed of Kir6.2 and SUR2A subunits (Inagaki et al. 1996; Okuyama et al. 1998) , whereas in central neurons and pancreatic β-cells they consist of Kir6.2 and SUR1 subunits . Whilst it is appreciated that K ATP channels are directly regulated by intracellular ATP, MgADP (Nichols, 2006) and phosphatidylinositol-4,5-bisphophate (PIP 2 ; Fan & Makielski, 1997; Baukrowitz et al. 1998; Shyng & Nichols, 1998) , how these important channels are modulated by more complicated intracellular signalling processes is far less understood.
The gaseous messenger nitric oxide has a fundamental biological role in protecting the heart against ischaemia-reperfusion injury (Bolli, 2001) . It has been suggested that NO shortens action potential duration (APD) 90 and increases maximal diastolic potential in the heart, by activating sarcolemmal K ATP (sarcK ATP ) channels via a cGMP-dependent mechanism (Baker et al. 2001) . Nitric oxide also potentiates the action of potassium channel openers (KCOs) on the K ATP channel in single ventricular cells, yet with conflicting findings on whether cGMP is involved (Shinbo & Iijima, 1997; Han et al. 2002) . The intracellular mechanism by which NO modulates cardiac K ATP channels has remained largely unknown.
In the present study, we combined single-channel patch-clamp recordings with pharmacological and biochemical approaches to delineate the intracellular signalling mechanism responsible for NO modulation of cardiac sarcK ATP channels. Human embryonic kidney (HEK) 293 cells expressing recombinant cardiac-type K ATP (i.e. Kir6.2/SUR2A) channels and ventricular cardiomyocytes freshly isolated from adult rabbits as well as from CaMKIIδ gene-null and wild-type mouse models expressing endogenous K ATP channels were used. Specifically, we investigated the involvement in NO signal transduction of soluble guanylyl cyclase (sGC), cGMP-dependent protein kinase (PKG), reactive oxygen species (ROS), hydrogen peroxide (H 2 O 2 ), calmodulin, calcium/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated protein kinase (ERK)1/2 of the mitogen-activated protein kinase (MAPK) family. Here we show that functional modulation of ventricular sarcK ATP channels by NO induction is mediated by intracellular signalling via a novel sGC-cGMP-PKG-ROS(H 2 O 2 )-ERK1/2-calmodulin-Ca MKII (CaMKIIδ isoform in particular) signalling pathway that alters the open and closed properties of the channel, enhancing channel activity.
Methods

Ethical approval
All protocols involving animals were approved by the institutional Animal Care and Use Committee at the University of California, Davis, and experiments were performed in strict accordance with the Guide for the Care and Use of Laboratory Animals 8th edition (2011) of the National Research Council, USA and conformed to the principles of UK regulations as described by Drummond (2009) .
Construction of cDNAs
To reconstitute cardiac ventricular-type K ATP channels, cDNAs encoding the pore-forming subunit Kir6.2 (mouse; gift from Dr. Susumu Seino at Kobe University, Chuo-ku, Japan) and the regulatory subunit SUR2A (rat; gift from Dr. Joseph Bryan at Baylor College of Medicine, Houston, TX, USA) were subcloned into mammalian expression vectors pIRES-EGFP (Clontech, Mountain View, CA, USA) and pcDNA3 (Invitrogen, Carlsbad, CA, USA), respectively. The plasmids to be used for transient transfection were prepared with Qiagen maxipreps and verified by DNA sequencing (Qiagen, Valencia, CA, USA).
Mammalian cell culture and transient transfection
The HEK293 cells (ATCC, Manassas, VA, USA) were maintained in Dulbecco's modified Eagle's medium DMEM/F12 (Mediatech, Herndon, VA, USA; supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 100 IU ml −1 penicillin and 100 μg ml −1 streptomycin) at 37°C in humidified air supplemented with 5% CO 2 . Cells were transiently transfected with expression plasmids containing cDNAs of interest using a modified calcium phosphate-DNA coprecipitation method (Chen & Okayama, 1987; Jordan et al. 1996) . Positive transfection was marked by cistronic EGFP expression provided by the vector pIRES-EGFP. The cells were replated the following day at a density of 5000-20,000 cells per dish onto 12 mm glass coverslips precoated with fibronectin (ß0.5 μg per coverslip, or 0.5 μg cm −2 ; Sigma-Aldrich, St Louis, MO, USA) to be recorded 48-72 h after transfection as previously described (Lin et al. 2000) .
Isolation of ventricular cardiomyocytes
Rabbits. Left ventricular myocytes were enzymatically isolated from adult New Zealand White rabbits as described before (Chai et al. 2011) . Rabbits were deeply anaesthetized by intravenous injection of pentobarbital sodium (80-100 mg kg −1 ). Hearts were excised and quickly placed on a Langendorff apparatus and perfused retrogradely for 5-7 min with nominally Ca 2+ -free Dulbecco's minimal essential medium solution. Perfusion was then switched to the same solution containing 1 mg ml −1 collagenase with up to 0.1 mg ml −1 neutral protease. Once the heart became flaccid (ß15-30 min), the ventricles were dispersed and filtered. The cell suspension was washed several times with medium containing ß150 μM Ca 2+ .
Mice. CaMKIIδ-null mice (generated as reported previously; Ling et al. 2009 ) and their littermate/wild-type controls were anaesthetized with isoflurane at 3-5% in 100% oxygen via a Bickford veterinary vapourizer with a flow rate of 1-2 l min −1 , followed by decapitation. Hearts were excised, and myocytes were dissociated from ventricles by enzymatic treatment. Isolated ventricular myocytes were subsequently plated on 12 mm glass coverslips freshly coated with laminin (ß1 μg per coverslip, or 1 μg cm −2 ; Invitrogen, Carlsbad, CA, USA) to enhance cell adhesion. Rod-shaped cells with clear margin and striation were used for immediate recordings.
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Electrodes, recording solutions and single-channel recordings
The recording electrodes were pulled from thin-walled borosilicate glass with an internal filament (MTW150F-3; World Precision Instruments, Sarasota, FL, USA) using a P-97 Flaming Brown puller (Sutter Instrument Co., Novato, CA, USA) and were firepolished to a resistance of 5-10 M . Cell-attached single-channel recordings (Hamill et al. 1981) were performed using a recording chamber (RC26; Warner Instruments, Hamden, CT, USA) filled with the intracellular (bath) solution, and the recording pipette was filled with the extracellular solution. For HEK293 cells, the intracellular (bath) solution consisted of (mM): KCl, 110; MgCl 2 , 1.44; KOH, 30; EGTA, 10; HEPES, 10; and sucrose, 30; pH adjusted to 7.2 with KOH. The extracellular (intrapipette) solution consisted of (mM): KCl, 140; MgCl 2 , 1.2; CaCl 2 , 2.6; and HEPES, 10; pH adjusted to 7.4 (with KOH). For cardiomyocytes, the intracellular (bath) solution consisted of (mM): KCl, 127; MgCl 2 , 1; KOH, 13; EGTA, 5; HEPES, 10; and glucose, 10; pH adjusted to 7.2 (with KOH). The extracellular (intrapipette) solution consisted of (mM): KCl, 140; MgCl 2 , 1; CaCl 2 , 2; HEPES, 10; and glucose, 10; pH adjusted to 7.4 (with KOH). The use of symmetrical recording solutions (140 mM K + ) resulted in an equilibrium potential for potassium (E K ) and a resting membrane potential (V m ) around 0 mV, as determined from the I-V relationship of the K ATP channel. All recordings were carried out at room temperature, and all patches were voltage clamped at −60 mV (i.e. with +60 mV intrapipette potentials) unless specified otherwise. Single-channel currents were recorded with an Axopatch 200B patch-clamp amplifier (Molecular Devices: Axon Instruments, Sunnyvale, CA, USA), low-pass filtered (3 dB, 2 kHz) and digitized at 20 kHz online using Clampex 9 software (Axon Instruments) via a 16 bit A/D converter (Digidata acquisition board 1322A; Axon Instruments). [4,3-a] quinoxalin-1-one (ODQ), KT5823, N-(2-mercaptopro pionyl)glycine (MPG), 5-hydroxydecanoate (5-HD), fluphenazine-N-2-chloroethane (SKF-7171A), myristoylated autocamtide-2 related inhibitory peptide for CaMKII (mAIP), 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio)butadiene (U0126) and 2 -amino-3 -methoxyflavone (PD98059) were diluted from aliquots with bath recording solutions prior to use. Stock solutions were prepared as follows: zaprinast, pinacidil, KT5823, ODQ, SKF-7171A, U0126 and PD98059 in DMSO; and glycol-SNAP-2, NOC-18, MPG, 5-HD and mAIP in H 2 O; all were stored at −80°C in aliquots. Working solutions of catalase (human erythrocyte) and H 2 O 2 were prepared directly from original stocks immediately before use. All working drug solutions were put on ice and kept away from light. Drugs were applied through a pressure-driven perfusion system (BPS-8; ALA Scientific Instruments, Westbury, NY, USA) to the recording chamber via a micromanifold positioned closely to the patches. Reagents and chemicals were purchased from EMD Millipore (Calbiochem, Billerica, MA, USA) or Sigma-Aldrich (St Louis, MO, USA). For pharmacological blockade, individual groups of cells were pretreated with respective inhibitors (except catalase) at room temperature for at least 15 min before being subjected to functional assays.
Preparations of drugs
Working solutions of
N-(2-deoxy-α,β-D-glucopyranose- 2-)-N 2 -acetyl-S-nitroso-D,L-penicillaminamide (glycol- SNAP-2), DETA NONOate (NOC-18), 1,4-dihydro-5-(2- propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidine-7- one (zaprinast), pinacidil, 1H-[1,2,4]oxadiazolo
Electrophysiological data analysis
Data were analysed as described before (Lin et al. 2000 (Lin et al. , 2004 Mao et al. 2007; Chai et al. 2011) , using individual data files of 120 s durations.
Single-channel currents. Individual, digitized singlechannel records of 120 s duration (gap-free) were detected with Fetchan 6.05 (events list) of pCLAMP (Axon Instruments) using the 50% threshold crossing criterion and analysed with Intrv5 (gift from Dr. Barry S. Pallotta, formerly at University of North Carolina, Chapel Hill, NC, USA, and Dr. Janet Fisher at University of South Carolina, Columbia, SC, USA). Analysis was performed at the main conductance level (approximately 70-80 pS) for K ATP channels. Only patches with infrequent multiple-channel activity were used for single-channel analysis. Duration histograms were constructed as described by Sigworth & Sine (1987) , and estimates of exponential areas and time constants were obtained using the method of maximal likelihood estimation. The number of exponential functions required to fit the duration distribution was determined by fitting increasing numbers of functions until additional components could not significantly improve the fit (Horn, 1987; McManus & Magleby, 1988) . Events with duration less than 1.5 times the system dead time were not included in the fit. Mean durations were corrected for missed events by taking the sum of the relative area (a) of each exponential component in the duration frequency histogram multiplied by the time constant (τ) of the corresponding component. Each of the single-channel properties was then normalized to the corresponding controls obtained in individual patches (taken as one).
Multiple-channel currents. In patches where multiplechannel activities of K ATP channels were observed for more than 10% of the recording time, the digitized current records were analysed using Fetchan 6.05 (browse) of pCLAMP to integrate currents in 120 s segments. The current amplitude (I) values (current amplitude = integrated current/acquisition time) were then normalized to the corresponding controls obtained from the same patches to yield normalized open probability (NP o ; control value taken as one), because the normalized current amplitude is equivalent to the normalized NP o obtained from single-channel analysis when the single-channel conductance remains the same (Mao et al. 2007 ). The normalized NP o values obtained from both single-channel and multiple-channel patches were then pooled. In Fig. 1 and all other figures illustrating raw single-channel current records, representative traces (taken from individual 120 s files used for data analysis) with segments marked with a horizontal bar on top are displayed at increasing temporal resolution in successive traces (arranged from top to bottom).
CaMKII activity assay
Isolated rabbit ventricular myocytes were treated with NOC-18 (300 μM; chemical NO donor) or zaprinast (50 μM; selective inhibitor of cGMP-specific phosphodiesterases V and IX, capable of activating PKG) in the absence and presence of KT5823 (1 μM; selective PKG inhibitor) or U0126 [10 μM; selective mitogen-activated protein kinase kinase or MAPK kinase (MEK) inhibitor] for up to 30 min at room temperature. Immediately after the treatment, myocytes were homogenized using sonication in an ice-cold lysis buffer containing 50 mM HEPES, pH 7.5, 2 mg ml −1 bovine serum albumin, 5 mM EDTA and phosphatase inhibitor cocktail. CaMKII activity assays were then performed on fresh lysates as previously described (Wu et al. 2002; Erickson et al. 2008) . Briefly, CaMKII activity was measured as a function of 32 P-ATP incorporation into a synthetic substrate, syntide-2, by scintillation counter. Assays were performed at 30°C. Background measurements lacking syntide-2 were subtracted from experimental values. Kinase activity is expressed relative to baseline radiation from samples containing no cellular lysate. Each experiment was done in triplicate and repeated three times, unless otherwise noted.
Western blot analysis
Rabbit ventricular myocytes were treated and lysed as described under CaMKII activity assay (above). Immunoblotting for total and T287 phosphorylated CaMKII was performed via standard protocols. Equal amounts of protein were loaded and electrophoresed on 10% SDS-polyacrylamide gel before being transferred to a polyvinylidene difluoride membrane. Total CaMKII antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used at 1:1000 dilution. Phospho-specific CaMKII antibody (Affinity Bioreagents, Golden, CO, USA) was used at 1:1500 dilution. After incubation with the horseradish peroxidase-labelled secondary antibody, blots were developed using enhanced chemiluminescence (Pierce SuperSignal; Thermo Scientific, Rockford, IL, USA).
Statistics
Data are presented as means ± SEM. Statistical comparisons were made using Student's two-tailed one-sample, paired or unpaired t tests, or one-way ANOVA followed by Dunnett's multiple comparison tests to test the significance of difference in the following: normalized data (in response to treatment) in individual groups (Student's one-sample t tests); raw data pairs obtained before and during treatment in the same group (Student's paired t tests); normalized data between two separate groups (Student's unpaired t tests); or normalized data among multiple groups (one-way ANOVA followed by Dunnett's multiple comparison tests). Significance was assumed when P < 0.05. Statistical comparisons were performed using Prism (GraphPad Software, San Diego, CA, USA).
Results
Stimulation of Kir6.2/SUR2A channels by NO induction in intact HEK293 cells depends on PKG activation
To elucidate the underlying mechanism responsible for functional modulation of cardiac K ATP channels by NO, we first examined how Kir6.2/SUR2A (i.e. ventricular-type K ATP ) channels transiently expressed in HEK293 cells respond to NO induction. Single-channel recordings were performed in the cell-attached patch configuration to preserve integrity of the intracellular milieu for potential signalling. Bath perfusion of NOC-18 (300 μM), an NO donor which spontaneously releases NO in aqueous solution, markedly enhanced the single-channel activity of Kir6.2/SUR2A channels ( Fig. 1A shows a representative patch); the apparent opening frequency and the open duration were both increased, whereas the single-channel conductance remained the same. The averaged normalized NP o (i.e. relative channel activity) was increased to 4.84 ± 0.68 (control taken as one; Fig. 1G , filled bar; P < 0.0001, Student's two-tailed, one-sample t test; n = 15). In contrast, although pretreatment with the selective PKG inhibitor KT5823 did not alter the basal activity of these channels ( Fig. 1A and B) , K ATP channel stimulation evoked by NOC-18 was reduced by more than 50% in the presence of 1 μM KT5823 (following 15 min pretreatment; Fig. 1B and G, open bar; P < 0.01; n = 10), revealing significant attenuation of the NOC-18 effect by KT5823 ( 
(8)
The Authors. The Journal of Physiology C 2013 The Physiological Society ANOVA). The specificity of KT5823 at 1 μM to selectively inhibit activation of PKG but not that of cAMP-dependent protein kinase (PKA) has been verified in our recent study (Chai & Lin, 2010) . These data thus indicate that NOC-18 stimulated Kir6.2/SUR2A channels in intact HEK293 cells primarily via activation of PKG.
Effects of ROS scavengers and catalase on Kir6.2/SUR2A channel stimulation by NO induction ROS are identified as important mediators in intracellular signalling (Dröge, 2002; Finkel, 2011) . The NO donor S-nitroso-N-acetyl penicillamine (SNAP) has been shown to induce ROS generation in isolated rat cardiomyocytes (Xu et al. 2004 (Scherz-Shouval & Elazar, 2007) . In the presence of catalase (500 U ml −1 ), which provides a sink for endogenously generated H 2 O 2 , NOC-18 (300 μM) failed to elevate Kir6.2/SUR2A channel activity ( Fig. 1D and G, fourth bar from left), showing nearly complete blockade of the NOC-18 effect (Fig. 1G , filled vs. fourth bars; P < 0.01). These data indicate that ROS, and especially H 2 O 2 , were indispensible signals for NO stimulation of cardiac-type K ATP channels in intact HEK293 cells.
Inhibition of ERK1/2 abrogates Kir6.2/SUR2A channel stimulation by NO induction ERK1/2, a member of the MAPK family, is ubiquitously expressed and has many diverse cellular and physiological functions (Rose et al. 2010) . ERK1/2 may be activated by H 2 O 2 (Nishida et al. 2000) . We showed above that NO stimulation of Kir6.2/SUR2A channels required ROS/H 2 O 2 ; however, little is known about whether ERK plays a signalling role in acute NO modulation of ion channel function. To address this question, following pretreatment with U0126, which blocks activation of ERK1/2 through selectively inhibiting MEK1 and MEK2, cell-attached recordings were conducted in the continuous presence of U0126. Intriguingly, we found that NOC-18 (300 μM) was incapable of facilitating Kir6.2/SUR2A channel opening when U0126 (10 μM) was coadministered ( Fig. 1E and G, fifth bar from left); that is, the increase in the normalized NP o by NOC-18 was abrogated by blocking ERK1/2 activation ( Fig. 1G , filled vs. fifth bars; P < 0.01). These data indicate that ERK1/2, presumably activated downstream of ROS, was required for NO stimulation of cardiac-type K ATP channels.
Effect of CaMKII inhibitory peptides on NO stimulation of Kir6.2/SUR2A channels
Calcium/calmodulin-dependent kinases (CaMKs) influence processes as diverse as gene transcription, cell survival, apoptosis, cytoskeletal reorganization and learning and memory. CaMKII is the CaMK isoform predominantly found in the heart (Maier, 2009 ). Nevertheless, the potential involvement of CaMKII in NO signalling for cardiac K ATP channel modulation has never been investigated. In this set of experiments, we tested whether blocking CaMKII activation with mAIP (1 μM), a myristoylated autocamtide-2 related inhibitory peptide for CaMKII, interferes with Kir6.2/SUR2A channel (1 μM; B) ; N-(2-mercaptopropionyl)glycine (MPG, 500 μM; C); catalase (500 U ml −1 ; D); U0126 (10 μM; E); or myristoylated autocamtide-2 related inhibitory peptide selective for CaMKII (mAIP, 1 μM; F), showing that the NO donor NOC-18 increases recombinant Kir6.2/SUR2A channel activity in intact HEK293 cells, whereas the increase induced by NOC-18 is abated when PKG, ROS, H 2 O 2 , ERK1/2 or CaMKII is selectively inhibited. Patches were voltage clamped at −60 mV. Downward deflections represent openings from closed states. Segments of current traces (taken from individual 120 s data files) marked with a horizontal line atop are displayed in successive traces at increasing temporal resolution. Horizontal scale bars represent 1 s, 300 ms and 100 ms (top to bottom in each three-trace group), and vertical scale bars represent 4 pA. G, averaged normalized open probability (NP o ) of Kir6.2/SUR2A channels obtained from individual groups (control taken as one, indicated by dashed line; mean ± SEM of 7-15 patches), demonstrating that the stimulatory effect of NOC-18 on the normalized NP o (i.e. relative channel activity) of Kir6.2/SUR2A channels is dependent on PKG, ROS, H 2 O 2 , ERK1/2 and CaMKII. * P < 0.05, * * P < 0.01 and * * * * P < 0.0001 (Student's two-tailed, one-sample t test within groups, and one-way ANOVA followed by Dunnett's multiple comparison tests among groups).
J Physiol 592.5 stimulation induced by NOC-18 (300 μM). Subsequent to 15 min pretreatment with mAIP, coapplication of NOC-18 and mATP resulted in no significant change in the activity of Kir6.2/SUR2A channels acquired in cell-attached patches ( Fig. 1F and G, sixth bar from left), uncovering that mAIP nullified the stimulatory action of NOC-18 (Fig. 1G , filled vs. sixth bars; P < 0.01). These results thus indicate that NO modulation of Kir6.2/SUR2A channels in intact HEK293 cells relied on activation of CaMKII.
Effect of NO induction on sarcK ATP channels in intact rabbit ventricular myocytes: the dependence on sGC and PKG To evaluate the physiological relevance of NO signalling in cardiac K ATP channel modulation, cell-attached recordings as performed on HEK293 cells were conducted on ventricular cardiomyocytes freshly isolated from adult rabbits. In these native cells, pinacidil (100-200 μM), a KCO, was applied first to induce baseline sarcK ATP channel activity comparable to that seen in transfected HEK293 cells. The NO donors glyco-SNAP-2 (300 μM; Fig. 2A ) and NOC-18 (300 μM; Fig. 2B ) were then added, and both evoked marked increases in the opening and bursting frequencies and the bursting duration of ventricular sarcK ATP channels; the normalized NP o was raised to 8.29 ± 2.71 (control value in pinacidil taken as one; Fig. 2E , grey bar; P < 0.05) and 5.79 ± 1.51 (Fig. 2E , filled bar in black; P < 0.01), respectively, whereas the single-channel conductance remained unchanged. Moreover, to ensure that the stimulatory effect of NO induction on the normalized single-channel activity of rabbit ventricular sarcK ATP channels is not biased toward increases due to the low basal activity in the cell-attached patch configuration, the absolute NP o (i.e. NP o without normalization) values obtained in control and NOC-18-treated conditions were directly compared (Supplemental Fig. S1 ; a scatter plot). The averaged absolute NP o values were significantly increased, manifesting a positive effect of NOC-18 (nine data pairs; P < 0.05); the shift in the median points (Supplemental Fig. S1 , golden bars) was also consistent with an upward change caused by NOC-18. These results thus indicate that NO induction stimulated pinacidil-preactivated sarcK ATP channels in native ventricular cardiomyocytes, reinforcing our findings made on recombinant cardiac K ATP channels. By contrast, NOC-18 did not increase sarcK ATP channel activity in excised, inside-out patches (data not shown), excluding the possibility that the stimulation results from direct chemical modification of the channel by NO.
To identify signalling partners involved in NO modulation of the channel in native cardiomyocytes, we next examined whether NO modulation of ventricular sarcK ATP channels requires activation of sGC and PKG, by applying NOC-18 (300 μM) together with the selective sGC inhibitor ODQ (50 μM) or the PKG inhibitor KT5823 (1 μM), following pretreatment with respective inhibitors. The NOC-18 did not potentiate the single-channel activity of sarcK ATP channels preactivated by pinacidil in the presence of ODQ (Fig. 2C and E, open bar) or KT5823 ( Fig. 2D and E, hatched bar) , revealing annihilation of the stimulatory effect of NO donors ( Fig. 2E , P < 0.05 vs. filled bar in black). These results indicate that NO induction was capable of enhancing the function of sarcK ATP channels in native ventricular cardiomyocytes and that the enhancement was sGC-and PKG-dependent.
Suppression of ERK1/2 activity obliterates sarcK ATP channel stimulation elicited by NO donors in intact ventricular cardiomyocytes
Our findings obtained from the cloned K ATP channel Kir6.2/SUR2A expressed in HEK293 cells (see Fig. 1 ) revealed, for the first time, that ERK1/2 was required for NO modulation of cardiac K ATP channels. To substantiate these findings in a native cell setting, cell-attached patch-clamp recordings were conducted on rabbit ventricular myocytes pretreated with the ERK1/2 inhibitor U0126. Application of NOC-18 (300 μM) in the continuous presence of U0126 (10 μM) failed to elevate pinacidil-preactivated sarcK ATP single-channel activity ( Fig. 3A and E, open bar) ; the increase in the normalized NP o induced by NOC-18 was completely abolished (Fig. 3E, filled vs. open bars; P < 0.05). Likewise, in ventricular myocytes pretreated with PD98059, another ERK1/2 inhibitor, NOC-18 was unable to stimulate sarcK ATP channels when PD98059 (20 μM) was coapplied ( Fig. 3B and E, third bar from left; P < 0.05 vs. filled bar). These data consistently supported our hypothesis that activation of ERK1/2 mediates NO stimulation of sarcK ATP channels in ventricular myocytes.
Effects of antagonizing calmodulin and CaMKII on ventricular sarcK ATP channel stimulation caused by NO donors
To define the roles played by calmodulin (a ubiquitous calcium-binding protein) and CaMKII (activation of which depends on Ca 2+ /calmodulin binding) for sarcK ATP channel stimulation elicited by NO in ventricular cardiomyocytes, SKF-7171A, a selective calmodulin antagonist, and mAIP, the membrane-permeable inhibitory peptide for CaMKII, were respectively coapplied with NOC-18 (1 μM; D), illustrating that NO donors enhance ventricular sarcK ATP channel activity but the enhancement is reversed in the presence of inhibitors selective for sGC or PKG. Recording settings and scale bars are the same as described in the legend to Fig. 1 . E, averaged, normalized NP o in individual groups of cell-attached patches (n = 4-12), showing that the significant increase of sarcK ATP single-channel activity in intact ventricular cardiomyocytes induced by NO donors is abolished by inhibition of sGC or PKG. * P < 0.05; * * P < 0.01 (Student's one-sample t test within groups, and one-way ANOVA followed by Dunnett's multiple comparison tests among groups). 
NOC-18 ; D) , illustrating that the stimulatory effect of NOC-18 on native ventricular sarcK ATP channels is nullified when ERK1/2, calmodulin or CaMKII activity is suppressed. See Fig. 1 for definition of scale bars. E, summary data of the averaged normalized NP o obtained in individual groups of cell-attached patches (n = 4-12), demonstrating that stimulation of sarcK ATP channels by NO induction in intact ventricular cardiomyocytes requires activities of ERK1/2, calmodulin and CaMKII. The NOC-18 group data, the same as those shown in Fig. 2 , are included here for comparison purposes. * P < 0.05; * * P < 0.01 (Student's one-sample t test within groups, and one-way ANOVA followed by Dunnett's multiple comparison tests among groups).
during cell-attached patch-clamp recordings (following pretreatment). When coapplied with SKF-7171A (10 μM; Fig. 3C ) or mAIP (1 μM; Fig. 3D ), NOC-18 (300 μM) did not enhance ventricular sarcK ATP channel currents preactivated by pinacidil (Fig. 3E , fourth and fifth bars from left), yielding significant abrogation of the stimulatory effect of NOC-18 ( Fig. 3E ; P < 0.05 vs. filled bar for both groups). In agreement with the findings made in HEK293 cells (see Fig. 1 ), these results indicate that the stimulatory action of NO induction on ventricular sarcK ATP channels required activation of calmodulin and CaMKII.
Inhibition of ERK and CaMKII abolishes potentiation of sarcK ATP channel activity rendered by exogenous H 2 O 2 in ventricular cardiomyocytes
We showed in the preceding subsections that inhibition of ROS/H 2 O 2 , ERK and CaMKII could blunt functional stimulation of ventricular K ATP channels induced by NO donors in intact cells, revealing the involvement of these molecules as intracellular signalling partners mediating K ATP channel stimulation downstream of NO (induction). It is important to determine how ERK1/2 and CaMKII are positioned relative to ROS in the NO signalling pathway that enhances K ATP channel function. To address this, we examined whether the ability of exogenous H 2 O 2 to stimulate ventricular K ATP channels in intact cells is affected by inhibition of ERK1/2 and CaMKII (Supplemental Fig. S2 ). The rationale is as follows. If H 2 O 2 is generated endogenously after, and hence positioned downstream of, activation of ERK1/2 and CaMKII, the effectiveness of exogenous H 2 O 2 to stimulate sarcK ATP channels should not be compromised by suppression of either kinase. The same outcome is expected in the event that H 2 O 2 modulates sarcK ATP channels independently of these kinases. Conversely, if H 2 O 2 stimulates sarcK ATP channels via activation of ERK and/or CaMKII, the K ATP channel-potentiating capability of exogenous H 2 O 2 ought to be hampered by functional suppression of respective kinases. Interestingly, while application of H 2 O 2 (1 mM) reliably enhanced sarcK ATP single-channel activity preactivated by pinacidil in cell-attached patches obtained from rabbit ventricular cardiomyocytes, H 2 O 2 failed to elicit changes in K ATP channel activity when the MEK1/2 inhibitor U0126 (10 μM) or the CaMKII inhibitory peptide mAIP (1 μM) was coapplied (Supplemental Fig.  S2 Fig. 4A , inset; magenta colour (depicting NOC-18-treated condition) vs. black (depicting control)], while the shorter closed states were stabilized, resulting in shortening of the mean closed duration to 231.1 from 734.3 ms in this representative patch. Indeed, pooled data showed that NOC-18 decreased the normalized mean closed duration (control taken as one; 0.31 ± 0.07; P < 0.0001; n = 7) and increased the normalized opening frequency (5.10 ± 1.60; P < 0.05), thereby elevating the normalized NP o (i.e. relative channel activity; see Figs. 1G and 2E). Meanwhile, the longer open state became increasingly prominent in the presence of NOC-18 ( Fig. 4A, open; top vs. bottom panels), although neither the corrected mean open duration (1.65 ms in control condition vs. 1.75 ms in NOC-18) obtained from this patch nor the normalized mean open duration averaged from the whole group (control taken as one; 1.16 ± 0.15; n = 7) was significantly increased. By contrast, NOC-18 failed to evoke similar changes in the opening frequency (data not shown) and the open and closed duration distributions of ventricular sarcK ATP channels when the PKG inhibitor KT5823 (Fig. 4B) , the ERK1/2 inhibitor U0126 (Fig. 4C) or the CaMKII inhibitory peptide mAIP (data not shown) was coadministered, explicating the absence of NOC-18-induced increases in NP o in these conditions (see Figs. 1G, 2E and 3E) . Our findings thus indicate that NO induction potentiated ventricular K ATP channel activity by shortening and destabilizing long closures, whilst increasing the opening transitions of the channel, in a PKG-, ERK1/2-and CaMKII-dependent manner.
Genetic ablation of CaMKIIδ prevents PKG stimulation of ventricular sarcK ATP channels
The predominant CaMKII isoform in the heart is CaMKIIδ (Tobimatsu & Fujisawa, 1989 Summary data (C) obtained from individual groups demonstrate that, compared with wild-type counterparts, the increase in the averaged normalized NP o (control taken as one; dashed line) by PKG activation is diminished in CaMKIIδ-null ventricular myocytes (n = 7-9). * P < 0.05; * * P < 0.01 (Student's one-sample t test within groups, and unpaired t test between groups). D and E, biochemical analysis of CaMKII activity, showing that the activity of CaMKII in intact rabbit ventricular myocytes is increased by NO-PKG activation in an ERK1/2-dependent manner. Cardiomyocytes were treated with NOC-18 (300 μM) or zaprinast (50 μM) in the absence and presence of KT5823 (1 μM) or U0126 (10 μM) for 30 min, followed by preparation of cell lysates. The CaMKII activity was then assayed by Western blotting of phospho-CaMKII (p-CaMKII) relative to total CaMKII and by estimating 32 P incorporation of a synthetic CaMKII substrate. Representative Western blots (D) and the mean densitometric values of relative CaMKII activity (E) estimated by 32 P incorporation (filled bars) and by Western blots (p-CaMKII relative to total CaMKII values; open bars; n = 3) reveal that CaMKII activity in cardiomyocytes is elevated by NO induction and PKG activation, but the increase is attenuated when PKG or ERK1/2 activity is inhibited. Values are means ± SEM of three experiments of independent cell preparations. The kinase activity assay was conducted in triplicate each time. * P < 0.05; * * P < 0.01 (Student's one-sample t test within groups, and one-way ANOVA followed by Dunnett's multiple comparison tests among groups).
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Effects of NO induction and PKG activation on CaMKII activity in ventricular myocytes: involvement of ERK1/2
To seek direct evidence for CaMKII activation by NO and PKG in intact cells, two independent biochemical assays, Western blotting that measures autophosphorylation of CaMKII at T287 (p-CaMKII) and a kinase activity assay that detects 32 P-ATP incorporation into syntide-2, a synthetic substrate for CaMKII, were conducted. Isolated adult rabbit ventricular myocytes were treated with the NO donor NOC-18 (300 μM) and the PKG activator zaprinast (50 μM), respectively, for 30 min in the absence and presence of KT5823 (1 μM; PKG inhibitor) or U0126 (10 μM; ERK1/2 inhibitor), followed by preparation of cell lysates for subsequent assays to estimate CaMKII activity. Western blotting assays revealed that both zaprinast and NOC-18 elevated the p-CaMKII level (relative to total CaMKII; Fig. 5D , upper panel, lanes 2 and 4 from left; Fig. 5E , open bars; P < 0.01, Student's two-tailed, one sample t test; control taken as one); however, these increases were attenuated by KT5823 (Fig. 5D , upper panel, lanes 3 and 5 from left; Fig. 5E , open bars; P < 0.01 for NOC-18 vs. NOC-18 + KT5823 and P < 0.05 for zaprinast vs. zaprinast + KT5823, Dunnett's multiple comparison test following one-way ANOVA) and by U0126 (Fig. 5D, lower panel; Fig. 5E , P < 0.01 for zaprinast vs. zaprinast + U0126). In accordance with Western blot data, CaMKII activity measured by 32 P-ATP incorporation was also increased by NOC-18 and by zaprinast (Fig. 5E , filled bars; three independent runs of triplicates each time; P < 0.01 for both treatment groups), and the changes were significantly abated when KT5823 or U0126 was coadministered (Fig. 5E , filled bars; P < 0.01 vs. NOC-18 or zaprinast administered alone). These results indicate that CaMKII was activated by NO-PKG signal transduction in ventricular cardiomyocytes; additionally, the ERK1/2 dependence of CaMKII activation implies that ERK1/2 is likely to be positioned upstream of CaMKII in the signalling cascade triggered by NO-PKG.
Discussion
sGC and PKG are required for NO stimulation of cardiac K ATP channels NO represents one of the most important defenses against myocardial ischaemia-reperfusion injury (Jones & Bolli, 2006) ; meanwhile, the K ATP channel has been regarded as mandatory in acute and chronic cardiac adaptation to imposed haemodynamic load, protecting against congestive heart failure and death (Yamada et al. 2006) . NO may potentiate the action of KCOs on K ATP channels in ventricular cardiomyocytes (Shinbo & Iijima, 1997; Han et al. 2002) and activate sarcK ATP channels in normoxic and chronically hypoxic hearts (Baker et al. 2001 ). However, little is known about the intracellular mechanism responsible for NO modulation of cardiac K ATP channels. In the present study, we showed that induction of NO by chemical donors resulted in increases in Kir6.2/SUR2A (i.e. recombinant cardiac-type K ATP ) and KCO-induced native sarcK ATP single-channel activities in cell-attached patches obtained from intact HEK293 cells and ventricular cardiomyocytes, respectively. Moreover, the stimulatory action of NO donors was attenuated or abolished by selective inhibition of sGC and PKG, suggesting that NO induction enhances the function of cardiac K ATP channels in intact cells via activation of sGC and PKG. In contrast to a K ATP -potentiating effect observed in intact cells, NO donors did not increase ventricular sarcK ATP channel activity in excised, inside-out patches (data not shown), which is consistent with a working model that NO modulates K ATP channel function via intracellular signalling rather than direct chemical modification of the channel.
ROS, in particular H 2 O 2 , act as intermediate signals in NO-induced stimulation of cardiac K ATP channels
ROS are generated by all aerobic cells, and most endogenously produced ROS are derived from mitochondrial respiration (Liu et al. 2002) . They have been shown to contribute to cardioprotection afforded by ischaemic preconditioning (Baines et al. 1997 ). Among all ROS, H 2 O 2 is an attractive candidate for cell signalling, because it is relatively stable and long lived and its neutral ionic state allows it to exit the mitochondria easily (Scherz-Shouval & Elazar, 2007) . In the present study, increases in Kir6.2/SUR2A channel activity rendered by NO donors in intact HEK293 cells were aborted not only by the ROS scavenger MPG but also by the H 2 O 2 -decomposing enzyme catalase. These results suggest that ROS, and in particular H 2 O 2 , presumably produced downstream of PKG activation, mediate NO-induced stimulation of cardiac K ATP channels in intact cells. In line with our findings that support an NO-PKG-ROS signalling model, the NO donor SNAP has been demonstrated to increase ROS generation in isolated cardiomyocytes, which, importantly, requires activation of PKG (Xu et al. 2004) . It has also been shown that late and early preconditioning induced by NO donors is blocked by the ROS scavenger MPG, implying that ROS are involved in cardioprotection induced by (exogenous) NO (Takano et al. 1998; Nakano et al. 2000) ; in light of the present findings, protection by NO in the heart may involve ROS-dependent activation of myocardial sarcK ATP channels.
In addition to ROS, an involvement of the putative mitochondrial K ATP (mitoK ATP ) channel in mediating NO stimulation of cell-surface cardiac K ATP channels was also investigated. Opening of mitoK ATP channels has been suggested as a downstream event of PKG activation (Xu et al. 2004) . Our findings indicate that 5-hydroxydecanoate (5-HD), the specific antagonist for the putative mitoK ATP channel, significantly attenuated the increase in Kir6.2/SUR2A channel activity rendered by NOC-18 in intact HEK293 cells (Supplemental Fig.  S3 ). The results thus suggest that the mitoK ATP channel (or 'the 5-HD-sensitive factor'; see Chai & Lin, 2010) , like ROS, is an intermediate signal crucial for mediating functional enhancement of cardiac K ATP channels caused by NO. Activation of the mitoK ATP channel and ROS generation may be sequential or parallel events induced by NO. However, because ROS scavengers in intact cells completely abolish the stimulatory effect on cardiac K ATP channels rendered by NO induction (Fig. 1) and by activation of PKG (Chai et al. 2011) , whereas the stimulatory effect of exogenous H 2 O 2 on cell-surface K ATP channels is unaffected by 5-HD treatment (Chai & Lin, 2010) , it is conceivable that the mitoK ATP channel or the 5-HD-sensitive factor is positioned upstream of, not in parallel to, ROS/H 2 O 2 (generation) for K ATP channel modulation in the NO-PKG signalling pathway. Collectively, these results support our working model (Fig. 6) , where the putative mitoK ATP channel mediates ROS generation induced by NO induction to stimulate cell-surface K ATP channel activity. MitoK ATP channels and ROS are implicated in the cardioprotective effect of ischaemic preconditioning (Vanden Hoek et al. 1998; Pain et al. 2000) and the anti-infarct effect of NO in intact, isolated heart (Xu et al. 2004) . It is possible that NO exerts its cardiac protection by activating sarcK ATP channels via a PKG-mitoK ATP -ROS signalling mechanism.
ERK1/2 mediates NO-and H 2 O 2 -induced stimulation of cardiac K ATP channels
ERKs play pivotal roles in many aspects of cell functions and are activated by oxidative stress in some types of cells (Aikawa et al. 1997; Nishida et al. 2000) . Our present investigation revealed that increases in cardiac K ATP single-channel activity induced by NO donors in both ventricular cardiomyocytes and transfected HEK293 cells were abolished by inhibition of MEK1 and MEK2 (both upstream kinases of ERK1/2) with U0126 or PD98059. These results thus suggest that, like ROS, ERK1/2 is a key Figure 6 . Working model of the NO signalling pathway for functional modulation of ventricular sarcK ATP channels Based on evidence obtained from the present study, we suggest that induction of NO leads to sGC activation and cGMP generation, which in turn activates PKG and triggers downstream signalling that consists of (in sequence) ROS, ERK1/2, calmodulin and CaMKII, resulting in sarcK ATP channel stimulation. Signalling components involved are shown in rectangular or oval shapes (shaded); pharmacological reagents or genetic ablation employed in the present study targeting individual signalling components are also depicted, with inhibitory approaches positioned on the left and activators on the right. (Finkel, 2003) . It has been reported that in cardiac myocytes, ERKs are activated by H 2 O 2 transiently and in a concentration-dependent manner (Aikawa et al. 1997) . H 2 O 2 may regulate K ATP channel activity in ventricular cardiomyocytes (Goldhaber et al. 1989; Ichinari et al. 1996; Tokube et al. 1996) . Befittingly, exogenous H 2 O 2 enhances the single-channel activity of pinacidil-preactivated sarcK ATP channels in a concentration-dependent manner in intact rabbit ventricular myocytes (Chai et al. 2011) . In the present study, we found that the stimulatory action of exogenous H 2 O 2 on sarcK ATP channels in intact cardiomyocytes was abrogated when the ERK1/2 inhibitor U0126 was coapplied (Supplemental Fig. S2 CaMKII is one of the major regulators of Ca 2+ homeostasis in the heart, phosphorylating cardiac contractile regulatory proteins and modulating the function of cardiac ion channels (Zhang et al. 2004; Wagner et al. 2009 ). Binding of Ca 2+ /calmodulin activates CaMKII, by disinhibiting the autoregulatory domain of the kinase (Hudmon & Schulman, 2002 On the other hand, activation of CaMKII has recently been reported to promote internalization (endocytosis) of cardiac K ATP channels, reducing surface expression (Sierra et al. 2013) . It is possible that, through different downstream mechanisms, activity and surface expression of cardiac K ATP channels are differentially regulated by activation of CaMKII, as previously reported for cardiac inwardly rectifying potassium channels, IRK (i.e. cardiac Kir2.x channels that give rise to I K1 currents; Wagner et al. 2009 ). Notably, for IRK channels the increase in function predominates over the reduction in expression when CaMKII is activated (Wagner et al. 2009 ), resulting in an overall effect of channel stimulation. Our findings evidently support a working model where calmodulin and CaMKII serve as indispensible elements in the NO signalling pathway mediating functional enhancement, not suppression, of cardiac K ATP channels.
Involvement of CaMKIIδ
The CaMKII family consists of four closely related yet distinct isoforms (α, β, γ and δ). The major isoform of CaMKII in the heart is CaMKIIδ (Tobimatsu & Fujisawa, 1989) . Importantly, the present study revealed that genetic ablation of CaMKIIδ (i.e. CaMKIIδ knockout) diminished PKG stimulation of ventricular sarcK ATP channels, suggesting a crucial role of CaMKIIδ in mediating enhancement of ventricular sarcK ATP channel activity elicited by PKG activation. As PKG activation was required for NO stimulation of cardiac K ATP channels, these results thus suggest that CaMKIIδ is primarily responsible for functional effects rendered by NO elevation on sarcK ATP channels in intact ventricular myocytes. Increased short-term CaMKII activity may serve as beneficial negative feedback for calcium on repolarization of cardiomyocyte membranes (Wagner et al. 2009 ). Further study is required to identify the direct target(s) of CaMKII(δ) for K ATP channel stimulation. (Hudmon & Schulman, 2002) . Our biochemical evidence revealed that both the PKG activator zaprinast and the NO donor NOC-18 activated CaMKII in intact rabbit ventricular cardiomyocytes, as manifested by increases in autophosphorylation of CaMKII and incorporation of 32 P into CaMKII substrates. Importantly, activation of CaMKII induced by NOC-18 and by zaprinast was significantly attenuated by the PKG inhibitor KT5823, suggesting that CaMKII is activated by NO-PKG signal transduction in ventricular cardiomyocytes. Moreover, enhancement of CaMKII activity by zaprinast was reduced in the presence of the MEK1/2 inhibitor U0126, which further suggests that ERK1/2 mediates PKG-elicited activation of CaMKII, hereupon placing CaMKII downstream of ERK1/2 in the signalling cascade initiated by NO-PKG. In addition, we also examined the effect of coapplication of NOC-18 and zaprinast on CaMKII phosphorylation. Data obtained from this group revealed that coapplication of NOC-18 and zaprinast increased CaMKII phosphorylation (Supplemental Fig.  S4 ; n = 3), but the magnitude of increase did not exceed that rendered by zaprinast administered alone (see Fig. 5D and E). These results thus suggest that PKG and NO act through the same signalling mechanism to enhance CaMKII activity in cardiomyocytes, providing additional evidence supportive of our hypothesis that PKG mediates stimulation of CaMKII activity caused by NO. While H 2 O 2 can directly drive autonomous CaMKII activation in a Ca 2+ /calmodulin-dependent manner (Erickson et al. 2008) , our electrophysiological data showing that cardiac K ATP channel stimulation by exogenous H 2 O 2 and by NO donors was both abrogated by inhibition of ERK1/2, complemented by biochemical evidence discussed above, suggest that ERK is likely to be positioned downstream of ROS/H 2 O 2 but upstream of CaMKII in the NO signalling pathway, at least for cardiac K ATP channel modulation. In other words, these results collectively support a working model (see Fig. 6 ), in which Ca 2+ /calmodulin-dependent activation of CaMKII takes place after sequential activation of NO (induction), sGC, PKG, ROS/H 2 O 2 (generation) and ERK1/2 to mediate cardiac K ATP channel stimulation. In this NO-K ATP channel signalling pathway, the ability of ROS to activate CaMKII directly (Erickson et al. 2008) appears to be non-essential.
The residual effect caused by NO donors on K ATP channel potentiation in the presence of KT5823 observed in HEK293 cells (Fig. 1B and G) seemed to imply that in HEK293 cells, but not in ventricular cardiomyocytes, some yet-to-be-identified signal(s) besides PKG is also activated by NO induction to mediate K ATP channel stimulation. Even if NO induces PKG-independent signalling in addition to activation of PKG, the 'divergent' signals probably converge to one common pathway at or above the level of ROS in HEK293 cells, as evidenced by total abrogation of the NO donor effect by scavenging of ROS, or respective suppression of the more downstream signalling partners ERK1/2 and CaMKII (Fig. 1C-F) . It is worth mentioning that many of the intermediate signals required for mediating K ATP channel potentiation in the signalling mechanism proposed in this study (Fig. 6 ) may intersect with other signalling pathways in different intracellular conditions, and therefore, our findings do not exclude a possibility that the signalling molecules involved in K ATP channel modulation downstream of NO may also affect K ATP channel activity through some parallel signalling pathways. Further studies will be required to elucidate this possibility.
In conclusion, here we report, for the first time, that the function of ventricular sarcK ATP channels is modulated by NO induction via an intracellular signalling pathway consisting of sGC, PKG, ROS/H 2 O 2 , ERK1/2, calmodulin and CaMKII (CaMKIIδ in particular) that J Physiol 592.5 facilitates opening transitions while destabilizing long closures of the channel. Specifically, our study suggests that ERK1/2 mediates NO/PKG activation of CaMKII, thereby relaying the signal from elevation of NO (and ROS) to the sarcK ATP channel in cardiomyocytes, rendering heightened channel activity. The present study highlights the relevance of intracellular signalling mechanisms as effective functional regulators for K ATP channels. The signalling mechanism described herein may offer the framework to permit fine-tuning of K ATP channel activity in different intracellular conditions. Mechanistic understanding of K ATP channel regulation may provide insights into the development of strategies for the management of cardiovascular injury. It is noteworthy that K ATP channels, NO, PKG, ROS and ERK1/2 have also been implicated in cardiac protection/tolerance against ischaemic injury. Cardiac protection by NO from exogenous sources or endogenously released during the short episode of sublethal ischaemia may be mediated partly by K ATP channel stimulation. Hence, this NO-sGC-PKG-ROS-ERK1/2-calmodulin-CaMKII (CaMKIIδ in particular)-sarcK ATP signalling pathway may regulate cardiomyocyte excitability and contribute to endogenous cytoprotection in the heart.
